REV3L and colorectal adenocarcinoma: Some studies found that REV3L was overexpressed in human gliomas tissues resected before therapy compared with normal brain tissues[19], mismatch repair-defective, p53-/- colorectal adenocarcinomas compared with control tissues[43].